In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
about
Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activationCan blood gene expression predict which patients with multiple sclerosis will respond to interferon?Immunologic abnormalities in chronic fatigue syndromeImmunologic biomarkers associated with an acute exposure to exothermic byproducts of a ureaformaldehyde spillInfluence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trialSpecific inhibition of TH2-type cytokine production from human peripheral T cells by terfenadine in vitroEndogenous and recombinant type I interferons and disease activity in multiple sclerosisMicrofluidic sample preparation for diagnostic cytopathologyTherapeutic interference with leukocyte recirculation in multiple sclerosis.Increased prevalence of late stage T cell activation antigen (VLA-1) in active juvenile chronic arthritisIncrease in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis.Dual labelling of circulating CD8 cells in patients with multiple sclerosis.Decreased RORC-dependent silencing of prostaglandin receptor EP2 induces autoimmune Th17 cells.CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO.Strategies for treating autoimmune disease with monoclonal antibodies.Immunologic abnormalities in humans exposed to chlorpyrifos: preliminary observations.Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigensSuppressor and cytolytic cell function in multiple sclerosis. Effects of cyclosporine A and interleukin 2.Autoreactive T cells in multiple sclerosis.Oligoclonal T cell repertoire in cerebrospinal fluid of patients with inflammatory diseases of the nervous system.Regulation of interleukin 2 receptors on T cells from multiple sclerosis patients.Intraindividual changes of dipeptidyl peptidase-IV in peripheral blood of patients with rheumatoid arthritis are associated with the disease activity.Lymphatic-specific expression of dipeptidyl peptidase IV and its dual role in lymphatic endothelial functionVery late activation antigens (VLA) are human leukocyte-neuronal crossreactive cell surface antigens.Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system.Oligoclonal T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis.Murine T cells express a cell surface receptor for multiple extracellular matrix proteins. Identification and characterization with monoclonal antibodies.T-cell activation via CD26 and caveolin-1 in rheumatoid synoviumSoluble interleukin-2 receptors in ulcerative colitisVasomotor reactivity comparison in multiple sclerosis patients with white matter lesions and nonmultiple sclerosis subjects with white matter lesions in brain magnetic resonance imaging.Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease.Accumulation of plasma cells in inflamed sites: effects of antigen, nonspecific microbial activators, and chronic inflammationSpontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3+DR+ T cell subsetPotentiation of the immune response in HIV-1+ individualsDual implication of 2',3'-cyclic nucleotide 3' phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosisT lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis.Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responsesDipeptidyl peptidase-4 inhibitors: multitarget drugs, not only antidiabetes drugs.Immune mechanisms in the pathogenesis of demyelinating diseases.Expression of GLP-1 receptor and CD26 in human thyroid C-cells: The association of thyroid C-cell tumorigenesis with incretin-based medicine.
P2860
Q22254628-54EDC30D-D2D2-4B47-8AA3-0D50E3BA85F6Q24794318-82B85E9F-41BC-4E9C-8D20-3BC164452C30Q28240155-78E7C5BB-4A1A-4562-8D30-83B938F208EAQ28323076-0508428F-B518-49F9-86EC-1A9A09B8FB8AQ28367696-B2E340F4-6656-4C43-8888-E74762A273B4Q28372008-1788A905-FF48-43C8-92BB-36BF19EEEC96Q28728759-9CF4C8B9-A327-472A-93CD-27407476F03BQ30437375-E2784029-FA43-4C7C-A862-8A30F18C267BQ30884219-3A7ACB52-8490-4CC8-9C2C-C75C57D30915Q33560482-403420ED-D994-4023-9B56-61C763B4A611Q33562296-A5B4A530-F351-411A-ACC5-10FFF9477E30Q33630199-47DE392D-5975-4B82-8C63-61275C97EBA2Q33872546-4C382A55-B25A-48CE-9C83-3CFBC9B43FFFQ33947051-EA2B6B19-CE12-4475-8208-DA5AB88FA583Q34193193-5AA39933-AD83-429B-97B2-DB4B41BB48F8Q34306037-E8017372-236A-4A84-ACC2-306B170819B5Q34528036-CD2A4C7A-C3A0-4903-8F4F-9853943BE8E3Q34534919-3E501FD2-825B-40FC-8D44-5DDD04CE5B31Q35173092-1729E997-1202-49CA-A6A0-61BC96E54D74Q35462517-15FB89EA-6E52-4250-B0A5-022A881F3AB4Q35600460-F7A58FD3-0A7C-4299-8AE6-C67CA3164CA0Q35768486-20E57E67-10EC-4E73-B212-21F5A8B22954Q36098601-F7834299-1BC7-439E-82D2-501E144CFA11Q36352224-CA636864-DA44-47F4-99AC-9E07DF47E59EQ36353509-A57EA18E-811C-4FEC-85E8-AB415C0465CAQ36354790-9D2360DF-BDA8-42EA-BD23-6CBF16688B40Q36356393-493F53D0-3414-4335-9D79-862E337D6D2BQ36452687-C9CEAFFA-0CC6-4F96-A4B7-322EA694CE33Q36627074-89395F56-0C84-468F-B48D-96BF5ED9D105Q36629063-CAA722A0-3C1F-4462-BCF4-6229CA296686Q36911056-204D8564-1BB5-43BA-8417-336CC9774DD1Q36988927-5BA6AB3E-CF50-495A-998D-F7B80AAE6F2EQ36994696-57D31DAE-0039-429E-8F5E-02EAEC45B63BQ37353395-E1EAA97B-D18A-40EC-BFD4-C7E6D8E8580EQ37381504-F94CCC7D-9F1E-4950-BDAF-28F032E9CD1FQ37613627-6FF86A22-3E79-4EB3-8735-2E3317A805E5Q37712459-B363203E-31ED-4165-BFEC-0647DFB584E7Q38107546-B5CABA39-6191-462A-ABF7-DE52047E786FQ38219276-0FC516B8-B5F0-43B3-9EEE-B0E88FF9CCA0Q38814125-C690E5FD-BF69-4F88-89A6-5C33B140ED15
P2860
In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
description
1985 nî lūn-bûn
@nan
1985 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
In vivo activated T lymphocyte ...... ients with multiple sclerosis.
@ast
In vivo activated T lymphocyte ...... ients with multiple sclerosis.
@en
In vivo activated T lymphocyte ...... ients with multiple sclerosis.
@nl
type
label
In vivo activated T lymphocyte ...... ients with multiple sclerosis.
@ast
In vivo activated T lymphocyte ...... ients with multiple sclerosis.
@en
In vivo activated T lymphocyte ...... ients with multiple sclerosis.
@nl
prefLabel
In vivo activated T lymphocyte ...... ients with multiple sclerosis.
@ast
In vivo activated T lymphocyte ...... ients with multiple sclerosis.
@en
In vivo activated T lymphocyte ...... ients with multiple sclerosis.
@nl
P2093
P921
P1476
In vivo activated T lymphocyte ...... ients with multiple sclerosis.
@en
P2093
Manning ME
Reinherz EL
Schlossman SF
P304
P356
10.1056/NEJM198505303122201
P407
P577
1985-05-01T00:00:00Z